Watch the On-Demand Webinar Now!

Learn how Tuyen Nguyen, Principal Scientist at Alnylam Pharmaceuticals, Inc., leveraged an automated HighRes Biosolutions system to reinforce the company’s leadership position in the rapidly expanding market of RNAi therapeutics. 

Discussion Points:

• RNAi therapeutics as a new therapeutic class
• Automated system design, build, validation, and deployment
• Automated in vitro screening workflow

Goal Achieved:

• The automated in vitro siRNA screening workflow increases throughput, data quality, and capture, and reduces sample costs